Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Clinical trial delays cost biopharmaceutical companies billions annually, primarily driven by recruitment bottlenecks and participant dropouts.
Targeted Patient Matching
Algorithmic screening of anonymized patient data reduces recruitment timelines by up to 40%, significantly improving overall clinical trial ROI.
High manufacturing overhead and reimbursement complexity constrain widespread adoption of curative cell technologies.
While machine learning tools demonstrate high accuracy in medical imaging, hospital network implementation is hindered by legacy IT…
Biopharmaceutical firms utilizing machine learning models report a 30% reduction in early-stage molecule discovery timelines.
Widely blamed for weight, widely misunderstood, and less variable between people than assumed.
Pharmaceutical firms are leveraging decentralized clinical trial software and real-world evidence analytics to compress drug discovery cycles.
What an individual truly want something that’s why still never comes? Does the law of attraction work it’s…